Oana Herlea-Pana
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Oana Herlea-Pana has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
- Audrey Wang
Indian Springs School
1 shared publication Aung Moe Zaw
School of Biological Sciences, The University of Hong Kong, 6N01 Kadoorie Biological Sciences Building, Pokfulam Road, Hong Kong
1 shared publication- Billy Kwok Chong Chow
School of Biological Sciences, The University of Hong Kong, Hong Kong, China; Guoke Ningbo Life Science and Health Industry Research Institute, Ningbo, Zhejiang, China
1 shared publication - Chi Bun Chan
School of Biological Sciences, The University of Hong Kong
1 shared publication - Chi Wai Lee
School of Biomedical Sciences, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China
1 shared publication - Dan Wu
Department of Genetics, Heersink School of Medicine, UAB Comprehensive Diabetes Center, University of Alabama at Birmingham
1 shared publication
Latest Publications
- Open Access
- 17 April 2025
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 13
Targeting IRE1α improves insulin sensitivity and thermogenesis and suppresses metabolically active adipose tissue macrophages in male obese mice
Overnutrition engenders the expansion of adipose tissue and the accumulation of immune cells, in particular, macrophages, in the adipose tissue, leading to chronic low-grade inflammation and insulin resistance. In obesity, several proinflammatory subpopulations of adipose tissue macrophages (ATMs) identified hitherto include the conventional ‘M1-like’ CD11C-expressing ATM and the newly discovered metabolically activated CD9-expressing ATM; however, the relationship among ATM subpopulations is unclear. The ER stress sensor inositol-requiring enzyme 1α (IRE1α) is activated in the adipocytes and immune cells under obesity. It is unknown whether targeting IRE1α is capable of reversing insulin resistance and obesity and modulating the metabolically activated ATMs. We report that pharmacological inhibition of IRE1α RNase significantly ameliorates insulin resistance and glucose intolerance in male mice with diet-induced obesity. IRE1α inhibition also increases thermogenesis and energy expenditure, and hence protects against high fat diet-induced obesity. Our study shows that the ‘M1-like’ CD11c+ ATMs are largely overlapping with but yet non-identical to CD9+ ATMs in obese white adipose tissue. Notably, IRE1α inhibition diminishes the accumulation of obesity-induced metabolically activated ATMs and ‘M1-like’ ATMs, resulting in the curtailment of adipose inflammation and ensuing reactivation of thermogenesis, without augmentation of the alternatively activated M2 macrophage population. Our findings suggest the potential of targeting IRE1α for the therapeutic treatment of insulin resistance and obesity.
- 17 April 2025
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 13
Open AccessTargeting IRE1α improves insulin sensitivity and thermogenesis and suppresses metabolically active adipose tissue macrophages in male obese mice
Overnutrition engenders the expansion of adipose tissue and the accumulation of immune cells, in particular, macrophages, in the adipose tissue, leading to chronic low-grade inflammation and insulin resistance. In obesity, several proinflammatory subpopulations of adipose tissue macrophages (ATMs) identified hitherto include the conventional ‘M1-like’ CD11C-expressing ATM and the newly discovered metabolically activated CD9-expressing ATM; however, the relationship among ATM subpopulations is unclear. The ER stress sensor inositol-requiring enzyme 1α (IRE1α) is activated in the adipocytes and immune cells under obesity. It is unknown whether targeting IRE1α is capable of reversing insulin resistance and obesity and modulating the metabolically activated ATMs. We report that pharmacological inhibition of IRE1α RNase significantly ameliorates insulin resistance and glucose intolerance in male mice with diet-induced obesity. IRE1α inhibition also increases thermogenesis and energy expenditure, and hence protects against high fat diet-induced obesity. Our study shows that the ‘M1-like’ CD11c+ ATMs are largely overlapping with but yet non-identical to CD9+ ATMs in obese white adipose tissue. Notably, IRE1α inhibition diminishes the accumulation of obesity-induced metabolically activated ATMs and ‘M1-like’ ATMs, resulting in the curtailment of adipose inflammation and ensuing reactivation of thermogenesis, without augmentation of the alternatively activated M2 macrophage population. Our findings suggest the potential of targeting IRE1α for the therapeutic treatment of insulin resistance and obesity.
- 13 August 2019
- Published by American Association for the Advancement of Science (AAAS) in Science Signaling
- Vol. 12 (594)
Muscle-generated BDNF is a sexually dimorphic myokine that controls metabolic flexibility
BDNF produced by skeletal muscle in female mice enables switching of fuel sources during fasting.
- 13 August 2019
- Published by American Association for the Advancement of Science (AAAS) in Science Signaling
- Vol. 12 (594)
Muscle-generated BDNF is a sexually dimorphic myokine that controls metabolic flexibility
BDNF produced by skeletal muscle in female mice enables switching of fuel sources during fasting.